News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Saadvik Raghuram Y/LinkedIn
Jun 25, 2025, 20:47

Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC

Saadvik Raghuram Y, Head of Department of Medical Oncology at Arete Hospitals, shared a post on X:

“FDA approves Talectrectinib for ROS1-positive locally advanced or metastatic NSCLC.
  • Response rates in TKI naive (85-90%)
  • ORR in patients with prior TKI (52%)
  • CNS response rates in TKI Naive (73%), prior TKI (63%)
  • Watch out for Dizziness, QTc”

Read further.

Talectrectinib

More posts featuring Saadvik Raghuram Y on OncoDaily.

cancer FDA NSCLC OncoDaily Oncology ROS1-Positive NSCLC Saadvik Raghuram Y talectrectinib
Special Coverage
Insight
Jun 25, 2025, 20:47
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Career
Jun 25, 2025, 20:30
NFCR Awarded 2025 Szent-Györgyi Prize to Anthony R. Hunter for Progress in Cancer Research
Insight
Jun 25, 2025, 17:58
Shankar Siva: We Randomised the Final Patient on TROG Cancer Research 19.06 DECREASE Trial
Blog
Jun 25, 2025, 17:39
Julie Gralow: Pleased to Participate in This Well-organized Best of ASCO UAE Program in Abu Dhabi
Science
Jun 25, 2025, 16:50
Cedric Blanpain Shares New Study on the Role of Innate Immunity in Regulating Cell Plasticity and Reprogramming of Prostate Tumor Initiating Cells
Blog
Jun 25, 2025, 16:24
Results From Amgen's Phase 2 Obesity Study of Monthly Maritide Presented at the American Diabetes Association 85th Scientific Sessions
Blog
Jun 25, 2025, 16:13
Help Shape the Future of Cancer Care - Digestive Cancers Europe
Blog
Jun 25, 2025, 15:39
Raffaele Colombo: Dato-DXd Now Approved for Patients with EGFR-mutated NSCLC
Science
Jun 25, 2025, 15:25
Nakul Shah: Our Latest Review on Precision Oncology is out in The Oncologist
Blog
Jun 25, 2025, 14:56
Vaishali Paliwal Joins IGCS's Jump4June Challenge during Uterine Cancer Awareness Month
Blog
Jun 25, 2025, 14:30
Hathal Haddad: Salvage Brachytherapy - A Second Chance for Local Control
Blog
Jun 25, 2025, 14:17
Kyle Todd Shared New White Paper Analyzing Clinical Development Trends Across 594 ADCs with 142 Distinct Targets